Lv31
320 积分 2023-05-18 加入
The therapeutic age of the neonatal Fc receptor
7小时前
已完结
The Nonclinical Safety Assessment of a Novel Anti-CEACAM5 Antibody Exatecan Conjugate Predicts a Low Risk for Interstitial Lung Disease (ILD) in Patients—The Putative Mechanism Behind ILD
14天前
已完结
Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors
17天前
已完结
Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcγRIIb with Fc-engineered antibodies
20天前
已完结
Trends in the drug target landscape for autoimmune diseases
21天前
已完结
SKY59, A Novel Recycling Antibody for Complement-mediated Diseases
25天前
已完结
Selection of Payloads for Antibody–Drug Conjugates Targeting Ubiquitously Expressed Tumor-Associated Antigens: a Case Study
29天前
已完结
Development and Characterization of a Lysosome-Targeting SLC3A2/PD-L1 Bispecific Antibody-Drug Conjugate for Enhanced Anti-Tumor Efficacy in Solid Tumors
2个月前
已完结
Targeting IL-6 trans-signalling: past, present and future prospects
2个月前
已完结
Protein degraders push into novel target space
2个月前
已完结
The Underlying Mechanism of 3-Hydroxyphthalic Anhydride-Modified Bovine Beta-Lactoglobulin to Block Human Papillomavirus Entry Into the Host Cell
皖公网安备34019202002308
